Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry.

R.A Fathy,G.C Chamberlin,S.R Desai,H.W Lim,L.P Fox,K Blumenthal,A Tyagi,M Fassett,G.J Hruza,L.E French,H.L Greenberg,E.E Freeman,D.E Mcmahon,J.B Lipoff,M Rosenbach,C Lee,B.H Thiers

doi:10.1111/jdv.17646

Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry.

R.A Fathy, G.C Chamberlin + Show 15 more

Open Access

https://doi.org/10.1111/jdv.17646

Copy DOI

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV	Publication Date: Oct 5, 2021
Citations: 54	License type: NO-CC CODE

Affiliation: University of Pennsylvania, Massachusetts General Hospital, The University of Texas Southwestern Medical Center, Henry Ford Health System, University of California, San Francisco, University Dermatology, University of Miami, University of Nevada, Las Vegas, University of Charleston

#Department Of Dermatology #Massachusetts General Hospital + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Since December 2020, the American Academy of Dermatology and the International League of Dermatologic Societies' COVID-19 Dermatology Registry has tracked dermatologic reactions post-COVID-19 vaccination. Within months, a variety of cutaneous manifestations were reported after the Moderna and Pfizer-BioNTech COVID-19 vaccines.1 As of April 2021, a total of 672 possible vaccine-related skin reactions have been reported by healthcare providers. Here, we evaluate the first 40 cases of varicella zoster virus (VZV) and herpes simplex virus (HSV) reported in the registry after COVID-19 vaccination with either the Moderna or Pfizer-BioNTech vaccines.

Full Text